Orange Book product · Generic (ANDA)
FLUOCINONIDE
FLUOCINONIDE
At a glance
Jun 19, 2018
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 19, 2018
8 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
FLUOCINONIDE
Strength
0.05%
Dosage form
GEL
Route
TOPICAL
TE code
AB
Application
ANDA 209030
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FLUOCINONIDE
- 2005VANOSBrand (NDA)
NDA 021758 · BAUSCH
- 1984FLUOCINONIDEBrand (NDA)
NDA 019117 · SUN PHARMA CANADA
- 1984LIDEXBrand (NDA)
NDA 018849 · ALVOGEN
- —LIDEXBrand (NDA)
NDA 016908 · ALVOGEN
- —FLUOCINONIDEBrand (NDA)
NDA 017373 · ALVOGEN
- —LIDEXBrand (NDA)
NDA 016909 · ALVOGEN
- 2025FLUOCINONIDEGeneric (ANDA)
ANDA 216389 · QUAGEN
- 2020FLUOCINONIDEGeneric (ANDA)
ANDA 208989 · ZYDUS LIFESCIENCES
- 2019FLUOCINONIDEGeneric (ANDA)
ANDA 212976 · XIROMED
- 2019FLUOCINONIDEGeneric (ANDA)
ANDA 211758 · ENCUBE
- 2019FLUOCINONIDEGeneric (ANDA)
ANDA 207554 · SCIEGEN PHARMS
- 2018FLUOCINONIDEGeneric (ANDA)
ANDA 209699 · ENCUBE ETHICALS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
